San Diego-based mostly Viking Therapeutics marked by itself as a significant competitor within the weight loss drug marketplace in February after revealing promising info from a mid-phase trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when provided for a weekly injection As well as in March